Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison

BACKGROUND: Fluoropyrimidine-based regimens are the cornerstone of first-line chemotherapy for metastatic gastric cancer (GC). Capecitabine or S-1 might be used as an alternative to infusional 5-fluorouracil, especially in pan-Asian. This study aimed to compare the clinical outcomes of capecitabine-...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:J Gastrointest Oncol
Auteurs principaux: Wang, Jin, Li, Zhi, Qu, Jinglei, Song, Na, Chen, Ying, Cheng, Yu, Zhang, Simeng, Qu, Xiujuan, Liu, Yunpeng
Format: Artigo
Langue:Inglês
Publié: AME Publishing Company 2020
Sujets:
Original Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7475324/
https://ncbi.nlm.nih.gov/pubmed/32953151
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/jgo-20-52
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires